Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing.
Intracellular detection of virus infections is a critical component of innate immunity carried out by molecules known as pathogen recognition receptors (PRRs). Activation of PRRs by their respective pathogen-associated molecular patterns (PAMPs) leads to production of proinflamatory cytokines, including type I IFN, and the establishment of an antiviral state in the host. Out of all PRRs found to date, retinoic acid inducible gene I (RIG-I) has been shown to play a key role in recognition of RNA viruses. On the basis of in vitro and transfection studies, 5'ppp RNA produced during virus replication is thought to bind and activate this important sensor. However, the nature of RNA molecules that interact with endogenous RIG-I during the course of viral infection has not been determined. In this work we use next-generation RNA sequencing to show that RIG-I preferentially associates with shorter, 5'ppp containing viral RNA molecules in infected cells. We found that during Sendai infection RIG-I specifically bound the genome of the defective interfering (DI) particle and did not bind the full-length virus genome or any other viral RNAs. In influenza-infected cells RIG-I preferentially associated with shorter genomic segments as well as subgenomic DI particles. Our analysis for the first time identifies RIG-I PAMPs under natural infection conditions and implies that full-length genomes of single segmented RNA virus families are not bound by RIG-I during infection.
Baum
Alina
A
Department of Microbiology, Mount Sinai School of Medicine, New York, NY 10029, USA.
Sachidanandam
Ravi
R
García-Sastre
Adolfo
A
D002460:Cell Line; D000071457:DEAD Box Protein 58; D053487:DEAD-box RNA Helicases / Q000378:metabolism*; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000378:metabolism*; D011485:Protein Binding; D012367:RNA, Viral / Q000235:genetics / Q000378:metabolism*; D011971:Receptors, Immunologic; D029082:Sendai virus / Q000378:metabolism*; D017423:Sequence Analysis, RNA
D012367:RNA, Viral; D011971:Receptors, Immunologic; C452820:RIGI protein, human; D000071457:DEAD Box Protein 58; D053487:DEAD-box RNA Helicases
J Virol. 2005 Oct;79(20):12944-51
16188996
Proc Natl Acad Sci U S A. 2006 May 30;103(22):8459-64
16714379
Cell. 2005 Sep 9;122(5):669-82
16125763
Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2986-91
15710892
Virology. 1998 Dec 20;252(2):324-30
9878611
Mol Cell. 2008 Feb 1;29(2):169-79
18243112
Nat Immunol. 2004 Jul;5(7):730-7
15208624
J Virol. 1997 Mar;71(3):2138-45
9032347
Nature. 1977 Apr 28;266(5605):815-9
194158
Nature. 2006 May 4;441(7089):101-5
16625202
Science. 2006 Nov 10;314(5801):994-7
17038590
Immunity. 2005 Jul;23(1):19-28
16039576
Mol Cell. 2005 Sep 16;19(6):727-40
16153868
J Exp Med. 2008 Jul 7;205(7):1601-10
18591409
Immunity. 2009 Jul 17;31(1):25-34
19576794
Nat Biotechnol. 2006 May;24(5):559-65
16648842
Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12067-72
19574455
Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):582-7
17190814
Virology. 2006 Jul 20;351(1):101-11
16631220
J Immunol. 2005 Sep 1;175(5):2851-8
16116171
Cell. 2010 Feb 5;140(3):397-408
20144762
Nature. 2008 Jul 24;454(7203):523-7
18548002
Mol Cell. 2008 Feb 29;29(4):428-40
18242112
Nat Immunol. 2005 Oct;6(10):981-8
16127453
J Virol. 2005 Jul;79(13):8431-9
15956587
Science. 2006 Nov 10;314(5801):997-1001
17038589
Nature. 2007 Aug 16;448(7155):816-9
17653195
J Biol Chem. 2009 Jan 9;284(2):1155-65
19019822
Nature. 2005 Oct 20;437(7062):1167-72
16177806
J Immunol. 2008 Apr 1;180(7):4910-8
18354215